Evidence map›Paper›PMID 27275542›Full record

ArticleOncotarget2016

The reverse-mode NCX1 activity inhibitor KB-R7943 promotes prostate cancer cell death by activating the JNK pathway and blocking autophagic flux.

Zhou Long, BaiJun Chen, Qian Liu, Jiang Zhao, ZhenXing Yang, XingYou Dong, LiuBin Xia, ShengQuan Huang, XiaoYan Hu, Bo Song and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Metal Ion Signaling in Biomedicine.Chemical reviews · 2025
    Review
  3. Review
  4. S-acylation of CaChronic diseases and translational medicine · 2024
    Review
  5. Article
  6. NCX1/CaCell communication and signaling : CCS · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Sodium homeostasis in the tumour microenvironment.Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  15. Article
  16. Article
  17. OncoTargets and therapy · 2019
    Article
  18. Role of the MAPK/cJun NHAutophagy · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zhou LongDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
BaiJun ChenDepartment of Gastroenterology, First Affiliated Hospital, Medical College of Chengdu, Chengdu, 610500, China.
Qian LiuDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Jiang ZhaoDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
ZhenXing YangDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
XingYou DongDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
LiuBin XiaDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
ShengQuan HuangDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
XiaoYan HuDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Bo SongDepartment of Urology, First Affiliated Hospital, Third Military Medical University, Chongqing, 400038, China.
LongKun LiDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Xinqiao Hospital · CNArmy Medical University · CNFirst Affiliated Hospital of Chengdu Medical College · CNSouthwest Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We explored the effects of KB-R7943, an inhibitor of reverse-mode NCX1 activity, in prostate cancer (PCa). NCX1 was overexpressed in PCa tissues and cell lines, and higher NCX1 levels were associated higher PCa grades. At concentrations greater than 10 μM, KB-R7943 dose-dependently decreased PC3 and LNCaP cell viability. KB-R7943 also increased cell cycle G1/S phase arrest and induced apoptosis in PC3 cells. KB-R7943 increased autophagosome accumulation in PCa cells as indicated by increases in LC3-II levels and eGFP-LC3 puncta. Combined treatment with chloroquine (CQ) and KB-R7943 decreased P62 and increased LC3-II protein levels in PC3 cells, indicating that KB-R7943 blocked autophagic flux. KB-R7943 induced autophagosome accumulation mainly by downregulating the PI3K/AKT/m-TOR pathway and upregulating the JNK pathway. In xenograft experiments, KB-R7943 inhibited tumor growth. Combined treatment with KB-R7943 and an autophagy inhibitor inhibited growth and increased apoptosis. These results indicate that KB-R7943 promotes cell death in PCa by activating the JNK signaling pathway and blocking autophagic flux.

Indexed as

AnimalsApoptosisAutophagyCell CycleCell Line, TumorCell MovementCell SurvivalChloroquineHumansMaleMAP Kinase Kinase 4MAP Kinase Signaling SystemMiceMice, NudeNeoplasm InvasivenessPhagosomes2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateChloroquineMAP Kinase Kinase 4Sodium-Calcium Exchangersodium-calcium exchanger 1Thioureaapoptosisautophagycell deathNCX1prostate cancer

Identifiers

PMID27275542
PMCPMC5173116
OpenAlexW2419093532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.